BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
BOW
Bowhead Specialty Holdings Inc.
BOW has a slight edge over BAC overall on the model score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BOW Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
BOW's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BOW.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
BOW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $34.03 | — |
| Cheap | 16x | $28.41 | -17% |
| Fair | 18x | $32.73 | -3.8% |
| Current | 19x | $34.03 | — |
| Expensive | 34x | $60.90 | +79% |
Historical ranges are pointers, not guarantees.
BOW has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over BOW on the outlook, with more favorable profitability expectations.
BOW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BOW, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
BOW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +29% |
| Q3 2026 | $1.78 | +14% |
| Q2 2026 | $1.85 | +26% |
| Q1 2026 | $1.73 | +32% |
| Q4 2025 | $1.59 | +34% |
| Q3 2025 | $1.56 | +68% |
| Q2 2025 | $1.47 | +73% |
| Q1 2025 | $1.31 | +52% |
| Q4 2024 | $1.19 | +49% |
BOW has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over BOW on profitability, with a higher operating margin.
BOW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $171.8M | +19% |
| Q2 2026 | $163.9M | +23% |
| Q1 2026 | $155.7M | +27% |
| Q4 2025 | $151.7M | +27% |
| Q3 2025 | $143.9M | +23% |
| Q2 2025 | $133.3M | +35% |
| Q1 2025 | $122.7M | +35% |
| Q4 2024 | $119.3M | +44% |
BOW has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.3% | -4 points |
| Q2 2026 | 13% | +0.7 points |
| Q1 2026 | 13% | +1.4 points |
| Q4 2025 | 12% | -3.5 points |
| Q3 2025 | 13% | -0.3 points |
| Q2 2025 | 12% | +4.4 points |
| Q1 2025 | 12% | +1.8 points |
| Q4 2024 | 15% | +8.3 points |
BOW's operating margin was 9.3% last quarter, down 4 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BOW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $191.3M | +69% |
| Q2 2026 | $92.5M | -14% |
| Q1 2026 | $64.2M | +38% |
| Q4 2025 | $58.6M | -3.7% |
| Q3 2025 | $113.5M | -4.2% |
| Q1 2025 | $46.5M | +13% |
| Q4 2024 | $60.9M | +0.8% |
| Q3 2024 | $118.4M | +36% |
BOW's free cash flow was $407M over the past year, up 24% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BOW.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BOW on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BOW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.1% | +699K shares |
| 1 year | +1.8% | +606K shares |
| 3 years | +8.6% | +2.7M shares |
BOW has 34M diluted shares, up 1.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BOW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -2.8x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2024 | -2.0x | Net Cash |
| Q4 2023 | -3.4x | Net Cash |
BOW has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BOW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.2 | Neutral |
| Stochastic | 56.5 | Neutral |
BOW's weekly RSI is 69 (neutral) and its Stochastic is 57 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BOW on valuation relative to its sector.
BOW PE vs Financial Services Sector
| Metric | BOW | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 13x | 47% above |
| PE % | 55 | 27 | 28 pts above |
BOW is trading at 19x earnings, a 47% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BOW has stronger trend alignment. BAC is above 1 of 5 weekly averages versus BOW above 4 of 4.
BOW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.0 | 0.1% above |
| 20 week MA | $33.1 | 2.7% above |
| 50 week MA | $28.5 | 19% above |
| 100 week MA | $30.8 | 11% above |
BOW is in an uptrend: it's above all four of its weekly moving averages, and 11% above its 100-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
BOW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $25.7 | $34.5 | +34% |
| 2025 | $34.5 | $28.5 | -17% |
| 2026 YTD | $28.5 | $34.0 | +19% |
BOW has the edge over BAC on returns for 2026, with the stronger performance.